Purpose
This phase II trial studies the side effects and best dose of propranolol when administered concurrently with SOC neoadjuvant CRT in patients with esophageal carcinoma, with a safety lead-in and dose expansion cohort. Patients who are already on β-blockers will receive standard of care CRT and will be considered separately as a single arm prospective cohort
Full Title
Propranolol with Standard Chemoradiation for Esophageal Adenocarcinoma - A Combined Single Arm and Randomized Cohort Phase II Study
ClinicalTrials.Gov ID
NCT04682158
To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.